ANEMIA OF MALIGNANCY

Many factors may contribute to anemia in patients with cancer. This ar ticle describes the clinical presentation, laboratory features, and pa thophysiologic mechanisms that may be involved in patients with malign ant disease and emphasizes the importance of recognizing the treatable causes of anemia. New information about the role of tumor-associated cytokine production in the anemia of malignancy is discussed, together with evidence for the use of therapeutic recombinant erythropoietin.